The market for the vaccine to prevent cervical cancer has expanded by the greatest amount ever. The increased inoculation rate of the high-priced 'Gardasil 9' has led the total market growth. MSD, which owns two HPV vaccines - 'Gardasil' and 'Gardasil 9' - accounted for 97% of the total market, and boasted its overwhelming influence in the domestic market.

According to the industry research institution IQVIA on the 7th, the HPV vaccine market size in Q1 of this year was 22.9 billion won. This was a 55.5% increase from the same quarter of the previous year and the highest-ever quarterly sales record. The COVID-19 outbreak had temporarily slowed down market growth in the first half of las